UC partners with AstraZeneca to expand lung cancer screening
May 12, 2025 •
The University of California Lung Cancer Consortium and AstraZeneca announced a five-year partnership to expand the Healthy Lungs California initiative, which is aimed at increasing early lung cancer detection and reducing deaths from the disease.
Lung cancer is the leading cause of cancer-related deaths in the United States, yet California has the lowest screening rate in the country.
“This important initiative allows us to address critical gaps in screening and assess environmental factors — such as the impact of pollution and wildfires — that may increase lung cancer risk,” said Jonathan Goldman, M.D., chair of the UC Lung Cancer Consortium. “Together with AstraZeneca and community members, we will be working to expand our efforts further to help improve early lung cancer detection screening rates.”
Read the full story from the UC Health Newsroom
Tags: AstraZeneca, Healthy Lungs California, https://link.ucop.edu/wp-content/uploads/2025/05/lung_thumb.jpg, lung cancer, UC Lung Cancer Consortium
